Human papillomavirus type 7 (HPV-7) was originally identified in common warts of butchers. It has remained unclear, however, whether HPV-7 also induces other distinct types of cutaneous lesions. We observed similar keratoses on the groins of 2 patients. The lesions presented as multiple, smooth and small with little change in color from that of the adjacent skin and were diagnosed as condylomas. Their histological features were acanthosis, papillomatosis and parakeratosis with hyperkeratotic perinuclear vacuolation in the granular layer. By Southern blot analysis, HPV-7 DNA was identified in both condylomas. We conclude that HPV-7 infection causes condyloma. In addition, we discuss the long-held dogma regarding the association of HPV-7 with butcher’s warts and highlight the potential need for clinicians to know causal HPV types in cutaneous lesions given the increased use of prophylactic HPV vaccines.

Orth G, Jablonska S, Favre M, Croissant O, Obalek S, Jarzabek-Chorzelska M, Jibard N: Identification of papillomaviruses in butchers’ warts. J Invest Dermatol 1981;76:97–102.
Oltersdorf T, Campo MS, Favre M, Dartmann K, Gissmann L: Molecular cloning and characterization of human papillomavirus type 7 DNA. Virology 1986;149:247–250.
Ashida M, Ueda M, Kunisada M, Ichihashi M, Terai M, Sata T, Matsukura T: Protean manifestations of human papillomavirus type 60 infection on the extremities. Br J Dermatol 2002;146:885–890.
Matsukura T, Sugase M: Human papillomavirus genomes in squamous cell carcinomas of the uterine cervix. Virology 2004;324:439–449 (erratum published in Virology 2005;331:204–205).
Meffert JJ, Anthony JS: Butcher’s warts: dermatological heritage or testable misinformation? Arch Dermatol 2001;137:1655–1656.
Jablonska S, Obalek S, Favre M, Golebiowska A, Croissant O, Orth G: The morphology of butchers’ warts as related to papillomavirus types. Arch Dermatol Res 1987;279:S66–S72.
Rüdlinger R, Bunney MH, Grob R, Hunter JA: Warts in fish handlers. Br J Dermatol 1989;120:375–381.
De Villiers EM, Neumann C, Oltersdorf T, Fierlbeck G, zur Hausen H: Butcher’s wart virus (HPV 7) infections in non-butchers. J Invest Dermatol 1986;87:236–238.
Bunney MH, Benton C, Cubie HA: Viral Warts: Biology and Treatment. New York, Oxford University Press, 1992.
Jablonska S, Majewski S, Obalek S, Orth G: Cutaneous warts. Clin Dermatol 1997;15:309–319.
Greenspan D, de Villiers EM, Greenspan JS, de Souza YG, zur Hausen H: Unusual HPV types in oral warts in association with HIV infection. J Oral Pathol 1988;17:482–487.
De Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H: Classification of papillomaviruses. Virology 2004;324:17–27.
Matsukura T, Sugase M: Pitfalls in the epidemiologic classification of human papillomavirus types associated with cervical cancer using polymerase chain reaction: driver and passenger. Int J Gynecol Cancer 2008;18:1042–1050 (erratum published in Int J Gynecol Cancer 2008;18:1388).
Obalek S, Jablonska S, Favre M, Walczak L, Orth G: Condylomata acuminata in children: frequent association with human papillomaviruses responsible for cutaneous warts. J Am Acad Dermatol 1990;23:205–213.
Baden LR, Curfman GD, Morrissey S, Drazen JM: Human papillomavirus vaccine – opportunity and challenge. N Engl J Med 2007;356:1990–1991.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.